相关实验视频

Updated: Jul 22, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

儿科肺置换:临床挑战和新兴技术

Matthew Crago¹, David S Winlaw², Syamak Farajikhah¹

¹School of Chemical and Biomolecular Engineering The University of Sydney Sydney Australia.

Bioengineering & translational medicine

|July 21, 2023

概括

儿科肺置换 (PPVRs) 面临生物污染和患者生长的挑战,需要改进设备设计. 未来的PPVR需要增强生物相容性和增长适应性特征,以改善儿科患者的治疗结果.

科学领域:

生物医学工程生物医学工程
儿童心脏病学儿童心脏病学
材料科学材料科学材料科学

背景情况:

先天性心脏病 (CHD) 通常会影响右心室外流通道,导致儿童经常进行肺置换.
目前的儿科肺置换器 (PPVRs) 的生物相容性和耐久性都不够好,需要重复手术并造成重大负担.

研究的目的:

审查下一代儿科肺置换器 (PPVRs) 的临床挑战和生物工程方法.
探索跨学科的解决方案,以改善PPVR设计,解决生物污染和体质生长问题.
提供有关先进PPVR设计要求的见解,以提高患者的生活质量.

主要方法:

对儿科肺置换的临床经验的回顾.
对儿科患者体质生长相关的生理挑战的分析.
探索生物工程技术和防化学物质,用于门开发.

主要成果:

生物污染导致诸如血栓形成和感染之类的不良生物反应,导致PPVR失败.
儿科患者的体质生长会与植入的PPVR产生结构上的差异,从而限制了设备的寿命.
目前的PPVR需要经常重新操作,突出了对改进材料和设计的需求.

结论:

对于改善的儿科肺置换器 (PPVRs) 具有增强的生物相容性和耐用性,临床上有极大需求.
解决生物污染和适应儿科体质生长是开发下一代PPVR的关键.
临床医生和生物工程师之间的跨学科合作对于推进PPVR技术和改善患者治疗结果至关重要.

关键词:

生物污染是一种生物污染.儿科儿科儿科肺替换术肺替换术身体生长的体质增长

更多相关视频

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

相关概念视频

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Mitral Valve Prolapse II: Assessment and Management

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...

Mitral Valve Prolapse I: Introduction

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...